GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2026)

GoodRx Holdings has disclosed Non-Current Debt across 8 years of filings, most recently posting $481.6 million for Q2 2026.

• In Q2 2026, Non-Current Debt fell 0.7% year-over-year to $481.6 million; the TTM figure through Jun 2026 stood at $481.6 million (down 0.7% YoY), while the FY2025 annual figure was $483.3 million, down 0.71% from the prior year.
• Non-Current Debt came in at $481.6 million for Q2 2026 at GoodRx Holdings, roughly flat from $482.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $654.8 million in Q1 2022 to a low of $481.6 million in Q2 2026.
• Average Non-Current Debt over 5 years is $576.6 million, with a median of $646.2 million recorded in 2024.
• Year-over-year, Non-Current Debt slipped 0.61% in 2022 and retreated 24.89% in 2025.
• Over 5 years, Non-Current Debt stood at $651.8 million in 2022, then retreated by 0.63% to $647.7 million in 2023, then retreated by 24.86% to $486.7 million in 2024, then slipped by 0.71% to $483.3 million in 2025, then slipped by 0.35% to $481.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $481.6 million in Q2 2026, $482.4 million in Q1 2026, and $483.3 million in Q4 2025.